Back to Search Start Over

[Rhabdomyolysis due to drug-drug interaction of atorvastatin and cobicistat].

Authors :
Intert E
Krause M
Hennersdorf F
Knop K
Rosenkranz T
Source :
Innere Medizin (Heidelberg, Germany) [Inn Med (Heidelb)] 2022 Nov; Vol. 63 (11), pp. 1189-1193. Date of Electronic Publication: 2022 Aug 24.
Publication Year :
2022

Abstract

A 53-year-old man presented with rhabdomyolysis and acute kidney injury. The symptoms were presumably caused by a drug-drug interaction between an antiretroviral drug combination and atorvastatin. As a booster, cobicistat can also increase the toxicity of statins via inhibition of the enzyme cytochrome p450 3A4 (CYP3A4). After stopping atorvastatin and after intravenous fluid therapy, the symptoms regressed completely.<br /> (© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)

Details

Language :
German
ISSN :
2731-7099
Volume :
63
Issue :
11
Database :
MEDLINE
Journal :
Innere Medizin (Heidelberg, Germany)
Publication Type :
Academic Journal
Accession number :
36001111
Full Text :
https://doi.org/10.1007/s00108-022-01377-x